ArticleMolecular pharmaceutics

Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice.

Tamer A Elbayoumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.